跳至主要内容
临床试验/NL-OMON28051
NL-OMON28051已完成不适用

OBSERVATIONAL STUDY;<br>MYCOPHENOLATE SODIUM TREATMENT IN PATIENTS WITH PRIMARY SJOGREN’S SYNDROME – A PILOT TRIAL.

Professor Dr. Markus GaubitzMuenster University ClinicAlbert Schweitzer Sreet 3348129 Muenster Germanygaubitz@uni-muenster.deTel: +49-251-83575620 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11

研究概览

简要总结

  1. Gaubitz M, Schorat A, Schotte H, Kern P, Domschke W: Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial. Lupus 1999, 8:731-736;
    2. Willeke P, Domschke W, Gaubitz M: Mycophenolate Mofetil for the treatment of primary Sjögren's Syndrome: A case report. Ann Rheum Dis 2003, 62 (Suppl. 1) :352;
    3. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM: The management of Sjogren's syndrome. Nat Clin Pract Rheumatol 2006, 2:252-261.

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Diagnosis of primary Sjogren's syndrome based on the American-European Consensus criteria (Vitali et al.);
  • 2. Erythrocyte sedimentation rate >25mm/h and hypergammaglobulinemia (>1500 mg/dl);

排除标准

  • 1. Age below 18 or above 75 years;
  • 2. Pregnant or lactating women;

研究者

发起方
Professor Dr. Markus GaubitzMuenster University ClinicAlbert Schweitzer Sreet 3348129 Muenster Germanygaubitz@uni-muenster.deTel: +49-251-8357562

相似试验